Abstract
Malignant Mesothelioma: Asbestos are naturally occurring fibrous silicate materials. It is well recognised that inhalation of asbestos fibres especially amphiboles is the most important risk factor for developing mesothelioma. The epidemiological models of association between the risks of asbestos and malignant mesothelioma take into consideration not only cumulative exposure but also time since first exposure. Current epidemiological estimates suggest that mesothelioma will remain a public health problem for a number of years with epidemiological studies suggesting that the peak incidence of mesothelioma has not been reached. In the global context, mesothelioma remains responsible for between 15,000 - 20,000 deaths annually. Malignant mesothelioma can be divided as per World Health Organization classification into epithelioid, sarcomatoid, desmoplastic and biphasic subtypes.
Keywords: Asbestos, epidemiology, malignant mesothelioma, pathology.
Current Respiratory Medicine Reviews
Title:Epidemiology and Pathology of Malignant Mesothelioma
Volume: 12 Issue: 4
Author(s): Jack A. Kastelik, Mahmoud Loubani, Michael Greenstone, Simon Hart and Anne Campbell
Affiliation:
Keywords: Asbestos, epidemiology, malignant mesothelioma, pathology.
Abstract: Malignant Mesothelioma: Asbestos are naturally occurring fibrous silicate materials. It is well recognised that inhalation of asbestos fibres especially amphiboles is the most important risk factor for developing mesothelioma. The epidemiological models of association between the risks of asbestos and malignant mesothelioma take into consideration not only cumulative exposure but also time since first exposure. Current epidemiological estimates suggest that mesothelioma will remain a public health problem for a number of years with epidemiological studies suggesting that the peak incidence of mesothelioma has not been reached. In the global context, mesothelioma remains responsible for between 15,000 - 20,000 deaths annually. Malignant mesothelioma can be divided as per World Health Organization classification into epithelioid, sarcomatoid, desmoplastic and biphasic subtypes.
Export Options
About this article
Cite this article as:
Kastelik A. Jack, Loubani Mahmoud, Greenstone Michael, Hart Simon and Campbell Anne, Epidemiology and Pathology of Malignant Mesothelioma, Current Respiratory Medicine Reviews 2016; 12 (4) . https://dx.doi.org/10.2174/1573398X12666160817145726
DOI https://dx.doi.org/10.2174/1573398X12666160817145726 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Current Genomics The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger
Current Drug Targets Neuronal Semaphorins Regulate a Primary Immune Response
Current Neurovascular Research STING Activation and its Application in Immuno-Oncology
Current Topics in Medicinal Chemistry Genistein Potentiates the Anti-cancer Effects of Gemcitabine in Human Osteosarcoma via the Downregulation of Akt and Nuclear Factor-κB Pathway
Anti-Cancer Agents in Medicinal Chemistry Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
Current Medicinal Chemistry Ribonucleases and ImmunoRNases as Anticancer Drugs
Current Pharmaceutical Design Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Flavonoid-Based Cancer Therapy: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Towards Understanding the Role of Cancer-Associated Inflammation in Chemoresistance
Current Pharmaceutical Design Asbestos-Related Diseases: Still a Concern in Emerging Economies in the Absence of an International Ban
Current Respiratory Medicine Reviews Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Current Vascular Pharmacology Structural and Functional Diversity of Estrogen Receptor Ligands
Current Topics in Medicinal Chemistry Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Nitric Oxide: Cancer Target or Anticancer Agent?
Current Cancer Drug Targets TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Current Pharmaceutical Biotechnology Utilising Nanotechnology and Nanosystems for Treatment of Rare Diseases
Pharmaceutical Nanotechnology Neuroprotective Effects of Melanocortins in CNS Injury
Current Pharmaceutical Design Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer
Recent Patents on Anti-Cancer Drug Discovery